People

Senior Management

Scott Thacher, PhD, CEO and Director, founded Orphagen in 2001. He has 24 years of experience in life sciences research and pharmaceutical R&D. From 1993-2001, he directed programs in acne, psoriasis, hyperlipidemia, and diabetes at Allergan and served on management teams for strategic collaborations in dermatology and diabetes. Scott was previously on the biochemistry faculty as the Texas A&M College of Medicine (1986-1993) and holds a Ph.D. in biophysics from Harvard University and a B.S. in physics (Stanford).

Board of Directors

Tim Scott, J.D., Director and acting COO, is co-founder and President of Pharmatek Laboratories, a pharmaceutical drug development company. He is also a co-founder of Diakron Pharmaceuticals and serves as president of the Board of Trustees for The Children's School in La Jolla, California. He earned a B.A. in biochemistry from UCSD and a J.D. from the University of San Diego. He is a member of the California Bar.

Bob Shopes, Ph.D., Director, is founder and CEO of Tera Biotechnology Corp. Bob is a co-founder of Favrille Inc and served as President of Favrille from 2000 to 2002 and on the Board of Directors from 2000 to 2003. Prior to founding Favrille, Bob was the Director of Antibody Research at Stratacyte Corp. (a subsidiary of Stratagene). He holds a PhD in Biophysics from the University of Illinois, Urbana-Champaign and did postdoctoral work at Stanford University Medical Center.

Marvin Rosenthale, Ph.D., Director, serves on the Board of Directors of several private and public pharmaceutical companies. He is also an advisor to several venture capital funds. Previously, Marvin was President and CEO of Allergan Ligand Retinoid Therapeutics and Vice President Drug Discovery Worldwide at the R.W. Johnson Pharmaceutical Institute of Johnson & Johnson (NYSE: JNJ). He received a Ph.D. in Pharmacology from Hahnemann Medical College and Hospital, and an M.Sc. in Pharmacology and a B.Sc. in Pharmacy from the Philadelphia College of Pharmacy and Science.